Health Condition 1: null- patients suffering from type 2 diabets mellietus, on oral hypoglycemic agents.
Conditions
Interventions
Intervention1: Nishamalaki: Nishamalaki is a drug made from emblica officinalis and curcuma longa
route of administration -- Oral
Dosage 4gms once daily, early in the morning on empty stomach
with 0.2ml of honey
Control Intervention1: Tab Metformin
Tab Glimepiride: Tab Metformin less than 1000 mg/day
and/or Tab Glimepiride less than 3mg/day.
Oral hypo gylcemic agents
Dose used by the s
Frequency of administration- as per the blood sugar level. the dosage will be modified as per the patients responds to the treatment
Sponsors
Dr Mrs VAPandit
Eligibility
Inclusion criteria
Inclusion criteria: Patients satisfying all the following criteria would be included in the study: 1. Ready to abide by trial procedures and to give informed consent. 2. Either sex above 40 yrs 3. Type 2 diabetes mellitus for 4. Fasting blood glucose between 126- 234 mg % and post-prandial blood glucose (after a standard meal) between 162mg% to 360mg% 5. HbA1c between 7.0-9.5 %.
Exclusion criteria
Exclusion criteria: Patients suffering from any of the following conditions will be excluded from the study: a. Type 1 diabetes mellitus b. Patients with psychiatric disorder. c. Patients with H/o hematological disorders d. Complications of diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the effect of addition of Nishamalaki in patients of type II DM on oral hypoglycemic (OHA) agents on 1) Blood sugar level 2) HbA1c Timepoint: 0-3months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the effect of addition of Nishamalaki in patients of type II DM on oral hypoglycemic (OHA) agents on 1) Adverse reactions 2) Changes in the doses of OHAs Timepoint: 0-3months | — |
Countries
India
Contacts
Public ContactDr Jayshree Dawane
Bharati vidyapeeth deemed medical university
Outcome results
None listed